Cambridge, Ma., USA - April 22, 2016, Cambridge, Ma., USA - Visterra, Inc., a clinical-stage biotechnology company, announced the appointment of Bernadette Connaughton and Steven Holtzman to the company’s board of directors.
Article continues below
Ms. Connaughton and Mr. Holtzman each bring more than 30 years of strategic, operational and management experience in the biopharmaceutical industry to Visterra’s board and, in particular, experience in growing and leading companies and business units to generate significant value, as well as deep understanding of global pharmaceutical markets.
Ms. Connaughton has spent her career at Bristol-Myers Squibb, where she currently serves as Head,
European Markets, Canada and Australia.
She has held a variety of senior leadership positions at BristolMyers Squibb, including President-Intercontinental; President-Japan, Pacific Rim and Canada; Senior Vice President-U.S. Cardiovascular/Metabolic Business Unit; and Senior Vice President-Primary Care Marketing.
She has been on the European Markets and Patient Access Committees of the European Federation of Pharmaceutical Industry Associations since 2014.
Ms. Connaughton received a BA from Johns Hopkins University and an MBA from the University of Pennsylvania.
Mr. Holtzman most recently served as Executive Vice President, Corporate Development at Biogen, where he was responsible for business development and program leadership and management of the company’s late-stage product candidates and marketed products.
Previously he was the founder, CEO and chair of the board of directors of Infinity Pharmaceuticals.
Prior to that, Mr. Holtzman was an early leader and the Chief Business Officer of Millennium Pharmaceuticals, and was a founder, member of the board of directors and the Executive Vice President of DNX Corporation. He is currently a member of the board of directors of two private biotechnology companies, PMV Pharma and Molecular Partners. ■
New York Governor Kathy Hochul announced that AgriAmerica Fruit Products has completed the revitalization and upgrade of a 69,000-square-foot grape juice processing facility located at 200 Water Street in the Village of Fredonia.